OTC dandruff monograph
This article was originally published in The Tan Sheet
Executive Summary
The final monograph for OTC dandruff, seborrheic dermatitis and psoriasis drug products is being amended to include the combination of 1.8% coal tar solution and 1.5% menthol in a shampoo drug product to control dandruff, FDA says in a March 6 Federal Register notice. The regulation is effective April 5, 2007. The agency solicited comments on the proposed amendment in late 2005, but did not receive any responses (1"The Tan Sheet" Dec. 12, 2005, p. 6)...
You may also be interested in...
FDA Proposes Coal Tar/Menthol Addition To OTC Dandruff Monograph
The final monograph for OTC dandruff, seborrheic dermatitis and psoriasis drug products would be amended to include a specific combination of coal tar and menthol under a proposed rule published by FDA in the Federal Register Dec. 9
Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: